W Wu, L Guo, Y Fu, K Wang, D Zhang, W Xu… - Clinical reviews in …, 2021 - Springer
Anti-melanoma differentiation-associated gene 5–positive dermatomyositis (MDA5+ DM) is a rare autoimmune disease predominantly reported in East Asia. MDA5+ DM is an …
P Mehta, PM Machado, L Gupta - Rheumatology International, 2021 - Springer
Abstract Anti-Melanoma Differentiation-Associated gene 5 (MDA-5) Dermatomyositis (MDA5, DM) is a recently identified subtype of myositis characteristically associated with …
L Xu, H You, L Wang, C Lv, F Yuan, J Li… - Arthritis & …, 2023 - Wiley Online Library
Objective There is substantial heterogeneity among the phenotypes of patients with anti– melanoma differentiation–associated gene 5 antibody–positive (anti‐MDA5+) …
X Lu, Q Peng, G Wang - Nature Reviews Rheumatology, 2024 - nature.com
Anti-melanoma differentiation-associated protein 5 (MDA5) antibody-positive dermatomyositis (MDA5-DM) is a subtype of dermatomyositis. Although the aetiology and …
JC Hall, L Casciola‐Rosen, LA Samedy… - Arthritis care & …, 2013 - Wiley Online Library
Objective Autoantibodies against melanoma differentiation–associated protein 5 (MDA‐5) have been described in several Asian dermatomyositis (DM) cohorts, often associated with …
J Thuner, F Coutant - Autoimmunity Reviews, 2023 - Elsevier
Dermatomyositis with anti-melanoma differentiation-associated gene 5 antibody (anti-MDA5 DM) is a rare autoimmune disease, often complicated by life-threatening, rapidly progressive …
A Nombel, N Fabien, F Coutant - Frontiers in immunology, 2021 - frontiersin.org
Anti-MDA5 dermatomyositis is a rare systemic autoimmune disease, historically described in Japanese patients with clinically amyopathic dermatomyositis and life-threatening rapidly …
K Huang, O Vinik, K Shojania, J Yeung… - Rheumatology …, 2019 - Springer
The objective of the study was to determine the clinical features and treatment course in Canadian patients with dermatomyositis (DM) associated with the anti-melanoma …